- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about SAVA
Recent news which mentions SAVA
Cassava Stock Is a Bold Play That Could Pay Off Soon
September 13, 2021
From InvestorPlace
What Happens When A Biotech Stock Blows Up: How Our Hedged Portfolio Method Limited The Damage With Cassava Sciences
September 11, 2021
From Benzinga
Cassava Sciences Stock Still Poses Risks After Absorbing Data Controversy
September 09, 2021
From InvestorPlace
7 Busted Biotech Stocks Due for a Rebound
September 08, 2021
From InvestorPlace
Better Buy: Biogen vs. Cassava Sciences
September 04, 2021
From Motley Fool
Cassava Sciences CEO says ‘enormous profit motive’ behind N.Y. law firm’s fraud allegations
September 03, 2021
From MarketWatch
Fraud Allegations Are Unlikely to Keep Cassava Stock Down
September 03, 2021
From InvestorPlace
The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself
September 03, 2021
From Benzinga
Cassava Sciences Stock Will Fall Further on Data Manipulation Allegations
September 02, 2021
From InvestorPlace
Here's How You Handle a Volatile Stock Like Cassava Sciences
September 02, 2021
From Motley Fool
12 Health Care Stocks Moving In Wednesday's Intraday Session
September 01, 2021
From Benzinga
Wait to See How the Cassava Sciences Allegations Pan Out
August 31, 2021
From InvestorPlace
Even as It Struggles, Skillz Stock Is Worth Loading up on Here
August 31, 2021
From InvestorPlace
Insiders Like Cassava Sciences, Which Might Be Good News
August 30, 2021
From InvestorPlace
12 Health Care Stocks Moving In Monday's Intraday Session
August 30, 2021
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
August 30, 2021
From Benzinga
From InvestorPlace
60 Biggest Movers From Friday
August 30, 2021
From Benzinga
The Week Ahead In Biotech (Aug. 29- Sept. 4): Merck's Keytruda Regulatory Decision, Stray Earnings On Tap In a Light Week
August 29, 2021
From Benzinga
Cassava Sciences punches back, after Qaunterix took a swing by saying it didn’t interpret or prepare the disputed trial data
August 27, 2021
From MarketWatch
Mid-Afternoon Market Update: Crude Oil Rises 2%; Navios Maritime Acquisition Shares Climb On Merger News
August 27, 2021
From Benzinga
From Benzinga
35 Stocks Moving In Friday's Mid-Day Session
August 27, 2021
From Benzinga
Why the Cassava Sciences Bears Are Wrong
August 27, 2021
From Motley Fool
Why Cassava Sciences Is Plunging Again Today
August 27, 2021
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.